• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

FOXP3表达准确地定义了在转移性黑色素瘤病灶中选择性聚集的肿瘤内调节性T细胞群体。

FOXP3 expression accurately defines the population of intratumoral regulatory T cells that selectively accumulate in metastatic melanoma lesions.

作者信息

Ahmadzadeh Mojgan, Felipe-Silva Aloisio, Heemskerk Bianca, Powell Daniel J, Wunderlich John R, Merino Maria J, Rosenberg Steven A

机构信息

Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

出版信息

Blood. 2008 Dec 15;112(13):4953-60. doi: 10.1182/blood-2008-06-163048. Epub 2008 Sep 26.

DOI:10.1182/blood-2008-06-163048
PMID:18820132
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2954707/
Abstract

Regulatory T (T(reg)) cells are often found in human tumors; however, their functional characteristics have been difficult to evaluate due to low cell numbers and the inability to adequately distinguish between activated and T(reg) cell populations. Using a novel approach, we examined the intracellular cytokine production capacity of tumor-infiltrating T cells in the single-cell suspensions of enzymatically digested tumors to differentiate T(reg) cells from effector T cells. Similar to T(reg) cells in the peripheral blood of healthy individuals, tumor-infiltrating FOXP3(+)CD4 T cells, unlike FOXP3(-) T cells, were unable to produce IL-2 and IFN-gamma upon ex vivo stimulation, indicating that FOXP3 expression is a valid biological marker for human T(reg) cells even in the tumor microenvironment. Accordingly, we enumerated FOXP3(+)CD4 T(reg) cells in intratumoral and peritumoral sections of metastatic melanoma tumors and found a significant increase in proportion of FOXP3(+)CD4 T(reg) cells in the intratumoral compared with peritumoral areas. Moreover, their frequencies were 3- to 5-fold higher in tumors than in peripheral blood from the same patients or healthy donors, respectively. These findings demonstrate that the tumor-infiltrating CD4 T(reg) cell population is accurately depicted by FOXP3 expression, they selectively accumulate in tumors, and their frequency in peripheral blood does not properly reflect tumor microenvironment.

摘要

调节性T(T(reg))细胞常在人类肿瘤中被发现;然而,由于其细胞数量少且无法充分区分活化的T细胞群体和T(reg)细胞群体,其功能特性一直难以评估。我们采用一种新方法,在酶消化肿瘤的单细胞悬液中检测肿瘤浸润性T细胞的细胞内细胞因子产生能力,以区分T(reg)细胞和效应T细胞。与健康个体外周血中的T(reg)细胞类似,肿瘤浸润性FOXP3(+)CD4 T细胞与FOXP3(-) T细胞不同,在体外刺激后不能产生IL-2和IFN-γ,这表明即使在肿瘤微环境中,FOXP3表达也是人类T(reg)细胞的有效生物学标志物。因此,我们在转移性黑色素瘤肿瘤的瘤内和瘤周切片中计数FOXP3(+)CD4 T(reg)细胞,发现瘤内FOXP3(+)CD4 T(reg)细胞的比例与瘤周区域相比显著增加。此外,它们在肿瘤中的频率分别比同一患者或健康供体的外周血高3至5倍。这些发现表明,通过FOXP3表达可准确描述肿瘤浸润性CD4 T(reg)细胞群体,它们选择性地在肿瘤中积聚,且其在外周血中的频率不能正确反映肿瘤微环境。

相似文献

1
FOXP3 expression accurately defines the population of intratumoral regulatory T cells that selectively accumulate in metastatic melanoma lesions.FOXP3表达准确地定义了在转移性黑色素瘤病灶中选择性聚集的肿瘤内调节性T细胞群体。
Blood. 2008 Dec 15;112(13):4953-60. doi: 10.1182/blood-2008-06-163048. Epub 2008 Sep 26.
2
Intratumoral convergence of the TCR repertoires of effector and Foxp3+ CD4+ T cells.效应性 CD4+T 细胞和 Foxp3+CD4+T 细胞中 TCR 库的肿瘤内趋同。
PLoS One. 2010 Oct 26;5(10):e13623. doi: 10.1371/journal.pone.0013623.
3
Reduction of regulatory T cells in skin lesions but not in peripheral blood of patients with systemic scleroderma.系统性硬皮病患者皮损中调节性 T 细胞减少,但外周血中无此变化。
Ann Rheum Dis. 2011 Aug;70(8):1475-81. doi: 10.1136/ard.2009.116525. Epub 2010 Nov 19.
4
High frequency of tumor-infiltrating FOXP3(+) regulatory T cells predicts improved survival in mismatch repair-proficient colorectal cancer patients.肿瘤浸润性 FOXP3(+)调节性 T 细胞的高频率预示着错配修复功能正常的结直肠癌患者的生存改善。
Int J Cancer. 2010 Jun 1;126(11):2635-43. doi: 10.1002/ijc.24989.
5
Tumor-infiltrating lymphocytes contain a higher proportion of FOXP3(+) T lymphocytes in cervical cancer.在宫颈癌患者肿瘤浸润淋巴细胞中 FOXP3(+)T 淋巴细胞的比例更高。
J Formos Med Assoc. 2011 Sep;110(9):580-6. doi: 10.1016/j.jfma.2011.07.005. Epub 2011 Aug 12.
6
Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue.在结直肠癌组织中鉴定CD8+CD25+Foxp3+抑制性T细胞。
Gut. 2009 Apr;58(4):520-9. doi: 10.1136/gut.2008.158824. Epub 2008 Nov 20.
7
Increase in tumour-infiltrating lymphocytes with regulatory T cell immunophenotypes and reduced zeta-chain expression in nasopharyngeal carcinoma patients.鼻咽癌患者中具有调节性T细胞免疫表型的肿瘤浸润淋巴细胞增加及ζ链表达降低。
Clin Exp Immunol. 2009 Mar;155(3):412-22. doi: 10.1111/j.1365-2249.2008.03793.x.
8
Activated but not resting regulatory T cells accumulated in tumor microenvironment and correlated with tumor progression in patients with colorectal cancer.在结直肠癌患者中,肿瘤微环境中积累的活化而非静息调节性 T 细胞与肿瘤进展相关。
Int J Cancer. 2013 Mar 15;132(6):1341-50. doi: 10.1002/ijc.27784. Epub 2012 Sep 18.
9
Comparative approach to define increased regulatory T cells in different cancer subtypes by combined assessment of CD127 and FOXP3.通过联合评估CD127和FOXP3来定义不同癌症亚型中调节性T细胞增加的比较方法。
Clin Dev Immunol. 2011;2011:734036. doi: 10.1155/2011/734036. Epub 2011 Aug 28.
10
Inflammation-driven reprogramming of CD4+ Foxp3+ regulatory T cells into pathogenic Th1/Th17 T effectors is abrogated by mTOR inhibition in vivo.体内抑制 mTOR 可阻断炎症驱动的 CD4+Foxp3+调节性 T 细胞向致病性 Th1/Th17 T 效应细胞的重编程。
PLoS One. 2012;7(4):e35572. doi: 10.1371/journal.pone.0035572. Epub 2012 Apr 24.

引用本文的文献

1
Dynamic monitoring of lymphocyte subsets at different disease stages can predict the prognosis of acute myeloid leukemia especially in complete remission status.在不同疾病阶段对淋巴细胞亚群进行动态监测可预测急性髓系白血病的预后,尤其是在完全缓解状态下。
Sci Rep. 2025 May 17;15(1):17128. doi: 10.1038/s41598-025-01600-3.
2
Tumor-Infiltrating T Cells in Skin Basal Cell Carcinomas and Squamous Cell Carcinomas: Global Th1 Preponderance with Th17 Enrichment-A Cross-Sectional Study.皮肤基底细胞癌和鳞状细胞癌中的浸润 T 细胞:Th1 优势的全球格局与 Th17 富集——一项横断面研究。
Cells. 2024 Jun 3;13(11):964. doi: 10.3390/cells13110964.
3
Loss of Y in regulatory T lymphocytes in the tumor micro-environment of primary colorectal cancers and liver metastases.原发性结直肠癌和肝转移瘤微环境中调节性T淋巴细胞Y染色体的缺失
Sci Rep. 2024 Apr 24;14(1):9458. doi: 10.1038/s41598-024-60049-y.
4
Biomarkers for response to TIL therapy: a comprehensive review.针对 TIL 治疗反应的生物标志物:全面综述。
J Immunother Cancer. 2024 Mar 13;12(3):e008640. doi: 10.1136/jitc-2023-008640.
5
Insight into the significance of Foxp3 + tumor-infiltrating lymphocytes in squamous cell lung cancer.深入了解 Foxp3+肿瘤浸润淋巴细胞在鳞状细胞肺癌中的意义。
Clin Transl Oncol. 2024 Jul;26(7):1708-1715. doi: 10.1007/s12094-024-03392-w. Epub 2024 Feb 25.
6
What happens to regulatory T cells in multiple myeloma.多发性骨髓瘤中调节性T细胞会发生什么变化。
Cell Death Discov. 2023 Dec 21;9(1):468. doi: 10.1038/s41420-023-01765-8.
7
Skin Cancer Microenvironment: What We Can Learn from Skin Aging?皮肤癌微环境:我们能从皮肤衰老中学到什么?
Int J Mol Sci. 2023 Sep 13;24(18):14043. doi: 10.3390/ijms241814043.
8
Design, optimisation and standardisation of a high-dimensional spectral flow cytometry workflow assessing T-cell immunophenotype in patients with melanoma.评估黑色素瘤患者T细胞免疫表型的高维光谱流式细胞术工作流程的设计、优化与标准化
Clin Transl Immunology. 2023 Sep 7;12(9):e1466. doi: 10.1002/cti2.1466. eCollection 2023.
9
Association between Intratumoral CD8+ T Cells with FoxP3+ and CD163+ Cells: A Potential Immune Intrinsic Negative Feedback Mechanism for Acquired Immune Resistance.肿瘤内CD8+ T细胞与FoxP3+和CD163+细胞之间的关联:获得性免疫抗性的一种潜在免疫内在负反馈机制。
Cancers (Basel). 2022 Dec 15;14(24):6208. doi: 10.3390/cancers14246208.
10
Changes in the Immune Cell Repertoire for the Treatment of Malignant Melanoma.免疫细胞谱变化治疗恶性黑色素瘤。
Int J Mol Sci. 2022 Oct 27;23(21):12991. doi: 10.3390/ijms232112991.

本文引用的文献

1
Pillars Article: Control of Regulatory T Cell Development by the Transcription Factor Foxp3. Science 2003. 299: 1057-1061.支柱文章:转录因子Foxp3对调节性T细胞发育的控制。《科学》2003年。299卷:1057 - 1061页。
J Immunol. 2017 Feb 1;198(3):981-985.
2
OX40 triggering blocks suppression by regulatory T cells and facilitates tumor rejection.OX40激活可阻止调节性T细胞的抑制作用,并促进肿瘤排斥反应。
J Exp Med. 2008 Apr 14;205(4):825-39. doi: 10.1084/jem.20071341. Epub 2008 Mar 24.
3
Circulating tumor antigen-specific regulatory T cells in patients with metastatic melanoma.转移性黑色素瘤患者体内循环肿瘤抗原特异性调节性T细胞
Proc Natl Acad Sci U S A. 2007 Dec 26;104(52):20884-9. doi: 10.1073/pnas.0710557105. Epub 2007 Dec 18.
4
Administration of a CD25-directed immunotoxin, LMB-2, to patients with metastatic melanoma induces a selective partial reduction in regulatory T cells in vivo.向转移性黑色素瘤患者施用一种靶向CD25的免疫毒素LMB-2可在体内诱导调节性T细胞选择性部分减少。
J Immunol. 2007 Oct 1;179(7):4919-28. doi: 10.4049/jimmunol.179.7.4919.
5
Dendritic cells are specialized accessory cells along with TGF- for the differentiation of Foxp3+ CD4+ regulatory T cells from peripheral Foxp3 precursors.树突状细胞是与转化生长因子(TGF-)一起的特殊辅助细胞,可使外周Foxp3前体分化为Foxp3 + CD4 +调节性T细胞。
Blood. 2007 Dec 15;110(13):4293-302. doi: 10.1182/blood-2007-05-088831. Epub 2007 Aug 15.
6
Inability to mediate prolonged reduction of regulatory T Cells after transfer of autologous CD25-depleted PBMC and interleukin-2 after lymphodepleting chemotherapy.在进行淋巴细胞清除化疗后,自体CD25缺失的外周血单核细胞(PBMC)和白细胞介素-2转移后,无法介导调节性T细胞的长期减少。
J Immunother. 2007 May-Jun;30(4):438-47. doi: 10.1097/CJI.0b013e3180600ff9.
7
IL-2 and IL-15 each mediate de novo induction of FOXP3 expression in human tumor antigen-specific CD8 T cells.白细胞介素-2和白细胞介素-15均可介导人类肿瘤抗原特异性CD8 T细胞中FOXP3表达的从头诱导。
J Immunother. 2007 Apr;30(3):294-302. doi: 10.1097/CJI.0b013e3180336787.
8
Natural regulatory T cells and de novo-induced regulatory T cells contribute independently to tumor-specific tolerance.天然调节性T细胞和新生诱导调节性T细胞独立地促成肿瘤特异性耐受。
J Immunol. 2007 Feb 15;178(4):2155-62. doi: 10.4049/jimmunol.178.4.2155.
9
CD4+CD25high T cells are enriched in the tumor and peripheral blood of prostate cancer patients.CD4+CD25高表达T细胞在前列腺癌患者的肿瘤组织和外周血中富集。
J Immunol. 2006 Nov 15;177(10):7398-405. doi: 10.4049/jimmunol.177.10.7398.
10
CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells.CD127的表达与人类CD4+调节性T细胞的FoxP3及抑制功能呈负相关。
J Exp Med. 2006 Jul 10;203(7):1701-11. doi: 10.1084/jem.20060772. Epub 2006 Jul 3.